arrow
T

Tim Eisen

University of London
H指数:57
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Investigating the mechanisms of neoadjuvant olaparib and cediranib in renal cancer: results of arms 1 to 3 of the WIndow of opportunity in REnal cancer (WIRE) clinical trial

探究新辅助奥拉帕利和西地尼布在肾癌中的作用机制:WIndow of opportunity in REnal cancer (WIRE) 临床试验第1至3组的试验结果

2025-10-010
OAAI
Establishing the China–UK Cancer Prevention and Control Alliance

建立中英癌症预防与控制联盟

2025-09-010
PRE
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
2024-08-010
OA
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)
2022-06-2331
OA
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol

WIRE研究使用贝叶斯自适应设计的II期,多臂,多中心,非随机的机会窗口临床试验平台,用于证明可手术肾细胞癌的新型治疗策略的机制-研究方案

2021-11-188
OAAI
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis

通过LDCT筛查降低肺癌死亡率: UKLS随机试验结果和国际荟萃分析

2021-11-01138
OA
Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma
2021-02-1614
OA
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study
2017-07-0119
OAAI
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
2016-05-01239
OA